<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Targeted <z:e sem="disease" ids="C0812393,C0038661" disease_type="Mental or Behavioral Dysfunction;Injury or Poisoning" abbrv="">suicide</z:e> gene therapy for Epstein-Barr virus (EBV)-associated <z:hpo ids='HP_0002664'>neoplasms</z:hpo> was attempted by using EBV-based plasmid vectors coupled with hemagglutinating virus of Japan (HVJ)-liposome in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>Expression of EBV nuclear antigen (EBNA)1 is a common feature of the <z:hpo ids='HP_0002664'>neoplasms</z:hpo> associated with EBV </plain></SENT>
<SENT sid="2" pm="."><plain>When various leukemic cell lines were transduced with a vector carrying a marker gene and EBV replication origin of plasmid (oriP), the marker gene product was exclusively detected in cells expressing EBNA1 </plain></SENT>
<SENT sid="3" pm="."><plain>Transduction of <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> virus (HSV)-1 thymidine kinase (Tk) gene resulted in a marked reduction in viable cell number by <z:chebi fb="0" ids="465284">ganciclovir</z:chebi> (GCV) specifically in EBNA1 positive cells </plain></SENT>
<SENT sid="4" pm="."><plain>The results demonstrate that this virus-free system may be applicable to gene therapy of EBV-associated <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
</text></document>